RY

RAJESH KUMAR YADAV

National Institute of Immunology, Amity University, Indian Institute of Chemical Biology CSIR and Jadavpur University, University of Calcutta, All India Institute of Medical Sciences Patna

ORCID iD 0000-0002-4239-0428
Follow

About

I am a group leader of the Cancer Epigenomics Laboratory (CEL) at the National Institute of Immunology (NII), New Delhi, India. Our research program is to understand how epigenetic mechanisms contribute to cancer pathogenesis, genomic instability, and cancer immunotherapy. We are employing cellular and molecular biology approaches, including genomics, to study the function of histones and chromatin modifiers within an interdisciplinary research program. Our goal is to understand the mechanisms of histone mutations in tumor progression. Furthermore, we propose to enhance the antitumor potential of Chimeric antigen receptor (CAR) T cells by manipulating chromatin modifiers. Over the course of my research career, I was trained primarily as a biochemist, molecular cell biologist, and geneticist. During that period, I learned about proteins and their complexes in various systems, including protozoan parasites and yeast cells. We aim to develop cellular and chemotherapeutic agents for cancer management.

Employment

  • National Institute of Immunology Scientist-IV
    2023 - Present
  • Amity University Associate Professor and Ramalingaswami Fellow
    2022 - 2023
  • All India Institute of Medical Sciences Patna Ramalingaswami Re-entry Fellow equivalent to Assistant Professor
    2019 - 2021
  • Adamas University Assistant Professor
    2018 - 2019
  • St. Jude Children's Research Hospital Postdoctoral Research Fellow
    2011 - 2017

Education

  • Indian Institute of Chemical Biology CSIR and Jadavpur University PhD
    2006 - 2011
  • University of Calcutta M.Sc.
    2002 - 2004
  • University of Calcutta B.Sc
    1999 - 2002

Projects & Funding

Projects & funding information is unavailable.

Publications (21)